Abstract
The blood–brain barrier (BBB) is responsible for maintaining homeostasis within the central nervous system (CNS). Depending on its permeability, certain substances can penetrate the brain, while others are restricted in their passage. Therefore, the knowledge about BBB structure and function is essential for understanding physiological and pathological brain processes. Consequently, the functional models can serve as a key to help reveal this unknown. There are many in vitro models available to study molecular mechanisms that occur in the barrier. Brain endothelial cells grown in culture are commonly used to modeling the BBB. Current BBB platforms include: monolayer platforms, transwell, matrigel, spheroidal, and tissue-on-chip models. In this paper, the BBB structure, molecular characteristic, as well as its dysfunctions as a consequence of aging, neurodegeneration, or under hypoxia and neurotoxic conditions are presented. Furthermore, the current modelling strategies that can be used to study BBB for the purpose of further drugs development that may reach CNS are also described.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Brain injuries after cardiac arrest are recognized by American Heart Association as crucial area in clinical research. Each year almost 800,000 individuals are suffering from new or recurrent stroke (Christophe et al. 2020), while number of seniors and other patients with central nervous system (CNS) diseases are growing. The existing treatment strategies fall behind mainly due to the fact that development of drugs for brain disorders is slow in comparison to other therapeutic areas (Dong 2018).
Blood–brain barrier (BBB) is a delimiter between the blood and CNS (Sivandzade and Cucullo 2018). In vivo, BBB is defined by its ability to selectively regulate the permeability for substances to cross from the circulating blood into the brain (Logan et al. 2019). The BBB interface between the CNS and the blood protects against pathogens and toxic compounds as well as transports nutrients to the brain (Sivandzade and Cucullo 2018; Dunton et al. 2021; Pardridge 2022). The BBB major component is endothelial cells (ECs), which are connected with pericytes (PCs), astrocytes (ACs), and neurons. Monolayer of tightly sealed ECs expressing low paracellular and transcellular permeability. ECs form a selective barrier and regulate the substances entry into the brain due to tight junctions, specific molecular transporters, and polarized efflux pumps (Kaisar et al. 2017; Vatine et al. 2019; Dunton et al. 2021).
Several neurological diseases are associated with BBB breakdown. Post-mortem analyses revealed capillary leakages into the brain in Alzheimer’s disease (AD) patients. The proteins derived from the blood were found with Amyloid beta protein (Aβ), the main component associated with theory of AD pathogenesis (Sweeney et al. 2019). Endothelial and pericyte degeneration have been confirmed in AD and other neurodegenerations like Amyotrophic lateral sclerosis (Armulik et al. 2010; Sengillo et al. 2013).
BBB is an impregnable barrier for more than 98% of small molecule drugs that cannot pass the BBB. Therefore, brain drug development studies are based on only 2% of molecules that in a lipid-mediated diffusion manner can penetrate the BBB (Pardridge 2022). To improve transport through the BBB, carrier-mediated transport, receptor-mediated transcytosis, nanoparticles, or focused ultrasound can be used (Pardridge 2015; Yemisci et al. 2015; Burgess and Hynynen 2016; Thrippleton et al. 2019). Dynamic contrast-enhanced MRI stands for BBB permeability assessment in cerebral small vessel disease and other related conditions in clinical (Taheri et al. 2011).
Models of the human BBB allow to study the molecular transport in health and disease conditions (Bell et al. 2010; Kaisar et al. 2017; Hajal et al. 2022). The models development that allow to understand of BBB molecular structure and function can lead to design a solutions that enable the transport of therapeutic agents into the brain (Bergmann et al. 2018). Since barriers differ among animals and humans, BBB studies should be based on human-specific models: the simplest ones, such as Transwell, have a rigid surface that preclude cell–cell interactions, thereupon 3D technology (Vatine et al. 2019). BBB organoids can be considered as a reliable multicellular platform to study brain-penetrating agents, nevertheless, obtaining reproducible spheroids remains a challenge (Cho et al. 2017; Bergmann et al. 2018).
BBB studies can put the spotlight on potential treatment targets (Sengillo et al. 2013). Understanding the processes regulating barrier formation and function drives to development of many in vitro BBB models; patient-specific models would be the future of the modelling (Sivandzade and Cucullo 2018). In vitro models have been developed to mimic in vivo conditions. They comprise static and dynamic platforms built of different cell types, including primary cell lines, immortalized cell lines, and stem cells (Kaisar et al. 2017; Sivandzade and Cucullo 2018). Each of the available BBB models has some limitations, described in this review. They can be used for functional testing, to assess whether certain substances can penetrate or not the BBB.
The Blood–Brain Barrier Structure
The ECs are the main cells forming the BBB and are playing the crucial role in BBB functionality. Nevertheless, PCs, ACs, microglia, neuronal cells, and perivascular macrophages affect the ECs activity (Dunton et al. 2021). ECs are sealed with glycocalyx and transporter proteins on the luminal side and coated in the basement membrane, while the ACs, and PCs on the abluminal side (Knox et al. 2022). The BBB outer layer is created mainly by ACs, while the core is formed by ECs (Fig. 1). The PCs are ECs supportive cells, involved in inducing and maintaining BBB properties and integrity (Hladky and Barrand 2016; Jiang et al. 2018). Brain capillary diameter is modulated by PCs through vessel wall constriction, while ACs regulate the contractibility of intracerebral vessels (Peppiatt et al. 2006; Takano et al. 2007; Kuchibhotla et al. 2009). Fibronectin, laminin, collagen, and elastin structural proteins constitute the stable basement membrane (Bagchi et al. 2019). PCs share the basement membrane with ECs and are involved in the regulation of their differentiation, migration, and proliferation (Cardoso et al. 2010).
A neurovascular unit (NVU) is a functional structure built of brain vascular and neural components. There are neural (neurons, microglia, ACs, and oligodendrocytes) and vascular (ECs, PCs, and vascular smooth muscle cells) components of the NVU (Wang et al. 2021). BBB is located in the central part of NVU (Sweeney et al. 2019). Besides NVU cells, there is the non-cellular extracellular matrix (ECM) that conditions cell adhesion, and provides structural support and biochemical signals to the NVU cells (Zidarič et al. 2022).
EC layer is highly polarized. There is a significant difference in the composition of proteins in the luminal and abluminal side, and is metabolically active due to a very high density of mitochondria. The BBB metabolic activity is almost five times higher than in other blood-organ barriers, therefore, brain ECs form a selective diffusion barrier for substances entering the brain (Kaisar et al. 2017).
To maintain the homeostatic balance of the CNS, the transport of substances to and out of the brain has to be strictly regulated (Dunton et al. 2021). BBB cells express the bulk of transporters, efflux pumps, receptors, ion channels, and regulatory molecules (Sweeney et al. 2019). Extreme temperature, increase in inflammatory cytokines (especially IL-6), and reactive oxygen species (ROS) affect the BBB permeability (Bernardo-Castro et al. 2020). The disruption of BBB is attributable to age and can be considered as a hallmark of age-related disorders. Any disturbances in BBB function can lead to: ion dysregulation and neuronal dysfunction and degeneration, invasion of immune cells, toxins, and pathogens to the CNS. Breakdown of the BBB includes: increased leukocyte infiltration, changes in molecular transport, EC shrinkage, and loss of tight junction proteins (TJs) (Dunton et al. 2021; Knox et al. 2022).
Within the endothelial space among ECs, ACs, and PCs there are tight junction proteins, crucial for the barrier function. TJs form a multiprotein cytoplasmic proteins complex (zonula occludens-1 (ZO-1), ZO-2, ZO-3, and cingulin) and transmembrane proteins (junctional adhesion molecules (JAMs), occludin and claudin). The lack of any of these proteins meaningfully affects the BBB integrity and functionality (Zidarič et al. 2022).
In Vitro BBB Models
Cell Types
Brain microvascular endothelial cells (BMECs), or other ECs, are supported by basement membrane. Rat brain endothelial cells (RBE4), mouse brain endothelial cells (bEND.3) immortalized cell lines are most frequently involved in BBB in vitro studies due to their barrier properties (Lippmann et al. 2013). Besides those two rodent-origin cell lines, BBB hCMEC/d3 is used as a human model of BBB. (Weksler et al. 2013). All mentioned express endothelial markers such as claudin-5, ZO-1 and occludins (Watanabe et al. 2013; Sun et al. 2022). ACs, PCs, and microglia can be used for functional BBB formation (Bagchi et al. 2019). Analysis of molecular permeability constitutes a major application of BBB models (Wu et al. 2021; Hajal et al. 2022). Other applications are the assessment of the physiological and pathological responses to specific stimuli, CNS drug discovery, and drug permeability screening (Kaisar et al. 2017). Modelling of human-specific BBB is crucial as it significantly differs across species (Logan et al. 2019).
Pluripotent stem cells can serve as an experimental model to study brain architecture and neurodegenerative processes. The human cortical organoids (hCOs), three-dimensional, pluripotent stem cell-derived, allow to examine neurological disorders and initial development of the human brain. Developing functional vasculature is essential for neuron progenitor differentiation. Utilization of the human embryonic stem cells (hESCs) leads to the formation of vasculature-like network in hCOs. Human brain organoids transplanted to the mouse’s brain became entwined by murine vessels, and so cell survival and maturation increase (Mansour et al. 2018; Cakir et al. 2019).
iPSCs
Human-Induced Pluripotent Stem Cells (iPSCc) are generated from reprogrammed somatic cells. Somatic cells usually origin from a blood sample or a skin biopsy, returned to a stem cell-like state by introducing transcription factors: MYC, KLF4, SOX2, and OCT4. iPSCs like other stem cells can differentiate into many cell types. Use of targeted stimulation allows to obtain specific cell types, required for the research. iPSCc are widely used in neurological studies. This model is useful for studying brain structure as well as in drug screening (Wu et al. 2021). It allows to obtain the co-culture of cells required for BBB construct (Logan et al. 2019).
Vatine et al. obtained iPSC-derived brain microvascular endothelial-like cells that with ACs and neurons formed a tight monolayer with specific brain vasculature markers, creating a barrier and protect neural cells from toxins. iPSCs derived from patients with neurological diseases allow to predict a specific lack of transporters and affected barrier integrity. Created NVU allows to study of BBB functions, drug screening, and to model neurological disorders (Vatine et al. 2019). Kadry et al. used iPSCs-derived BMECs and transwell system to examine the effect of smoking and metformin on the BBB. The barrier integrity was assessed by ZO-1, claudin-5, and occludin expression and distribution. The results showed that, the expression of claudin-5 was significantly decreased and the distribution of ZO-1 was altered under harmful conditions (Kadry et al. 2021). Wei et al. differentiated mesenchymal stromal cells from human iPSCs and drugged mice with them. It resulted in improved BBB integrity and decreased inflammation in the mice’s CNS (Wei et al. 2023).
Despite its great potential, applying iPSCc has some limitations. Reprogrammed cell culture is heterogenic, iPSC-derived cells are lack of age-related epigenetics (Wu et al. 2021). Differentiation efficacy is limited as well (Logan et al. 2019). Moreover, most of the studies finally use 2D model with one type of reprogrammed cells, so without cell–cell interactions cannot imitate an in vivo-like environment (Wu et al. 2021).
Models
2D cell cultures based on extracellular matrix components and one cell type have been used to study cell signaling pathways and cellular responses. Three-dimensional cell cultures involve extracellular matrices, hydrogel cultures, spheroids, and solid scaffolds (Kaisar et al. 2017). 3D models (spheroids) are a way out for a better understanding of the cell interactions among BBB cell types. However, transwell-based modeling systems, brain microvessels, extracellular matrix-based modeling platforms, and microfluidic systems have been used to study BBB as well (Table 1) (Waldau 2019; Wu et al. 2021).
2D Models
The simplest in vitro BBB models are human 2D monolayer platforms. ECs are seeded on the top of the hydrogel layer (often collagen) or on porous membrane. Sometimes ACs, PCs, or neurons are added to the culture. This method is simple and easy. Nevertheless, limited due to the lack of interactions among various BBB cells and gives a poor prognosis for drug-tissue interactions. Buzhdygan et al. used a 2D and a 3D vessel-like in vitro models to examine the spike protein of SARS-CoV-2 that affects the function of the BBB and compromises its properties. 2D monolayer platforms can be used to test functional outcomes of the BBB, but the properties of the model are limited. Permeability of 2D BBB model is one to three times higher than in vivo ones (Buzhdygan et al. 2020; Hajal et al. 2022).
Transwell Model
The structural limitation of the 2D models led to the development of 3D BBB models (Aazmi et al. 2022). The transwell can be used for monolayer cell culture (Wu et al. 2021; Rice et al. 2022). This is currently the most commonly used method to study BBB. Co-culture of ECs, PCs, and ACs represents much better morphology and integrity of the barrier, when compared with monoculture of ECs or ECs cultured with PCs or ACs alone (Nakagawa et al. 2009). Particular cell lines can be seeded on both sides of the membrane with tiny pores to achieve contact co-culture. Transport mechanisms can be studied as the membrane separates luminal and abluminal parts (Fig. 2A). This one is cost-effective and fast. Few days are enough to obtain co-culture for functional testing, which make this model feasible for drug screening or genotyping. The transwell model can be used to determine endothelial integrity. Another possible use of transwell is: iPSC-derived cells is 3D culture with cells cultured in low-adherence conditions. Self-assembling into a tissue-like structure makes this model preferable to study neurotoxicity, disease modeling, and organogenesis. Culturing for several weeks allow to examine the long-term effects of drugs. However, the lack of shear-stress is the main disadvantage of transwell model and this type of co-culture system displays comparatively low levels of BBB regulatory proteins (Waldau 2019; Wu et al. 2021). Chung et al. have studied the effects of acute and chronic oxidative stress on the BBB in 2D and 3D models. BMECs derived from iPSCs cell line were used to assess the effect of H2O2 exposure on the BBB cells in transwell and 3D microvessels model. Exposition for 1 h represented the acute model, while over 10 days exposition was a chronic model. They hypothesized that tissue-engineered BMECs microvessels could enhance the response to oxidative stress and BBB model functionality (Chung et al. 2022).
Matrigel Models
Tube-like human BBB model, based on hollow structures (channels) in 3D Matrigel, allows to obtain a platform with PCs and ACs on the abluminal side of the ECs (Urich et al. 2013). In Matrigel model ECs form tube-like structures seeded in a gel structure. PCs adhere to ECs, and ACs are more loosely attached to the ECs-PCs complex (Fig. 2B) (Urich et al. 2013). Endovascular progenitor cells can form tubular structures in Matrigel due to their self-assembly properties (Waldau 2019). Matrigel, gelatin, fibronectin, and laminin are possible culture substrates for neural cells (Komura et al. 2015). Matrigel is a gelatinous, high in various CNS proteins extracellular matrix mixture secreted by Engelbreth-Holm-Swarm mouse sarcoma cells (Berg et al. 2018; Wang et al. 2022). This substrate promotes the differentiation of various cell types (Kleinman and Martin 2005). Patel and Alahmad have studied the impact of different Matrigel sources on iPSCs differentiation into brain ECs. Matrigel provides growth factors and basement membrane for the maturation and differentiation of iPSCs into specific neural cells, allow to reconstruction of vasculogenesis. At the same time the source of Matrigel is of little consequence (Patel and Alahmad 2016). 3D Matrigel Model can be used to induce vascularized human brain organoids. This model has led to use 3D printing and bioprinting (Simöes Da Gama and Morin-Brureau 2022). Using the bioactive materials to introduce them into living cells allows to generate 3D model to study physiological mechanisms. 3D tissue models are very useful for infection experiments (Berg et al. 2018). A human BBB model with ECs, ACs, and PCs in 3D gel matrix mimics the permeability and gene expression profile observed in vivo. ECs derived from iPSCs were cultured with primary brain ACs and PCs to form the BBB microvascular networks (MVNs) (Waldau 2019). This type of material for the generation of organoids is not expensive and widely available but may be immunogenic. Furthermore, there is also poor control of mechanical properties of the scaffold (Kozlowski et al. 2021). Vascular permeabilities remain relatively close to the permeability in 2D models as well (Hajal et al. 2022).
Spheroidal Model
BBB spheroids were established to study the transport of brain penetrating agents and organogenesis (Campisi et al. 2018). The use of iPSCs may allow to formation of patient-specific BBB models. ECs maintain their phenotype, cellular interactions, gene expression, vessel morphology, and functional barrier properties. In spheroidal models, ECs, ACs, and PCs auto-assemble without scaffolding material. ECs form the outer layer of the spheroid, when the PCs align as a monolayer on the surface and ACs form an astrocytic core. PCs separate the other two cell types (Fig. 2C) (Waldau 2019; Hajal et al. 2022). To build a spheroidal model, more neural cells should be used: microglia, oligodendrocytes, and neurons (Bhalerao et al. 2020). Neurons added to the culture increase the sensitivity to oxygen–glucose deprivation and better represent the interactions in the NVU (Stone et al. 2019).
In the spheroid model, cells are cultured in low-adherence conditions. Different cell types can be cultured together, so tissue-like structure can be obtained in the way of self-assembling. There are many possible applications of spheroidal models: to study organogenesis, neurotoxicity, cellular viral infectivity, permeability and function of different drugs, long-term effects of drugs, disease modelling. The integrity of spheroid can be tested only once, that can be considered as major disadvantage of the model, since transwell and tissue-on-chips models allow to perform of permeability tests many times (Wu et al. 2021).
Usage of the BBB spheroidal model is an appropriate tool to examine efflux of the ABCB1 substrates, including rhodamine123 and doxorubicin (Eilenberger et al. 2021). The spheroid surface exhibits a high expression of tight junction proteins. This 3D model allows imaging of tight-junction and transporter proteins, gene, and protein analysis (Hajal et al. 2022). Glycoprotein P (P-gp) and GLUT-1 proteins have a crucial role in the disposal of unwanted chemical compounds and the transport of glucose, respectively (Bhalerao et al. 2020). TJ proteins, claudin-5, and ZO-1 are a hallmark of BBB occurrence, confirming monolayer integrity (Fig. 3A) (Ozgür et al. 2022). Fluorescent cell labeling of spheroids enables identification of each cell type and cell interactions based on the presence of specific proteins: β-catenin, P-gp, and ZO-1 confirm 3D cellular organization and cell–cell contact, requisite for cell differentiation and barrier formation (Fig. 3B) (Cho et al. 2017). Knox et al. have shown that, the level of β-catenin, P-gp, and ZO-1 on the surface of spheroid is significantly higher than in the transwell model, even if ECs were co-cultured with PCs and ACs. Co-culture in transwell model have improved BBB tightness in comparison to 2D cell culture. Nevertheless, in the spheroidal model there is a direct cell–cell contact required for proper barrier formation (Nakagawa et al. 2009; Hatherell et al. 2011; Urich et al. 2013; Knox et al. 2022).
Tissue-on-Chip
Tissue-on-a-chip approach uses microfluidic channels. A porous membrane is sealed among the channel networks, so cell populations can be introduced from both sides of the membrane and allowed to attach. The porous membrane among the cell culture chambers allows the migration of substances and interactions among different cell types similar to the transwell model. This technique has been used to establish many barrier models including the gut, lung, and vasculature. It is promising for drug delivery and CNS neurotoxicity studies (Kaisar et al. 2017). Wang et al. and Kilic et al. differentiated iPSCs into neuronal and astroglial cells. Wang et al. have developed brain organoids and confirmed that tissue-on-chip models allow to create microenvironment for brain organoids development, while Kilic et al. have studied cell migration due to gradients of chemotactic cues (Kilic et al. 2016; Wang et al. 2018). Tissue-on-Chip technique mimics an in vivo microenvironment, therefore tissues can be modeled more realistic. It enables to generate of shear stress through stimulated blood flow in BBB models (Wu et al. 2021). Microfluidic systems allow to control the 3D cellular and extracellular matrix; while they mimic cell-to-cell interactions and structures. They are referred as ‘tissue-on-a-chip’ (Campisi et al. 2018). The most used methods for the tissue-on-a-chip BBB model are live and dead cell imaging, permeability assays, immunofluorescence staining. qPCR is not very appropriable due to smaller cell amount than in other models (Wu et al. 2021). Moreover, currently available models using microfluidic channels still cannot precisely imitate in vivo BBB structure and function (Aazmi et al. 2022).
Molecular Characteristic of BBB
BBB regulates the transition of substances between the blood and the cerebral parenchyma and, therefore, maintains the brain microenvironment (Fu et al. 2021). The barrier controls the transport of molecules, so neuronal function and chemical composition depend on the BBB permeability. NVU cells are involved in: the regulation of BBB permeability, oxygen delivery, neurotransmitter turnover, neurogenesis, and angiogenesis. Physiological BBB transport is based on molecular junctions of the barrier, endothelial, and pericyte transporters (Sweeney et al. 2019). TJs and adherent junctions (AJs) enhance the BBB separation function and limit the transcytoplasmic transport (Pandit et al. 2020).
AJs proteins include: transcellular components, Ve-cadherin, platelet endothelial cell adhesion molecule-1 (PECAM-1), endothelial cell-selective adhesion molecule (ESAM), and JAMs (Knox et al. 2022). PECAM-1 and VE-cadherin are specific for endothelial cell-to-cell interactions (Vorbrodt and Dobrogowska 2003). ESAM, JAM-A, -B, and -C modulate junctional tightness similar to other AJs (Fig. 4) (Garrido-Urbani et al. 2014).
TJs are formed by the interaction among adjacent plasma membrane and integral transmembrane proteins (Bagchi et al. 2019). The TJ proteins include cadherins, catenins, claudins (claudin-1, -3, -5, -12), occludin, the membrane-associated guanylate kinase (MAGUK) protein family of zonula occludens (ZO-1, -2, -3) (Knox et al. 2022).
The BBB is enclosed by TJs (Tietz and Engelhardt 2015). Claudin-1, -3, -5, and -12 and occludin limit the ions paracellular transport and solutes across the BBB (Nitta et al. 2003). β-catenin stabilizes VE-cadherin and upregulates glucose transporter 1 (GLUT-1) and claudin-3 expression (once translocated into the nucleus) (Stenman et al. 2008). TJs are connected to the cytoskeleton via scaffolding proteins: ZO-1, -2, and -3 (Fig. 4) (Tornavaca et al. 2015). ZO-1 determines BBB tightness. Deficiency in claudins and ZO-1 is associated with BBB disruption and CNS diseases (Zlokovic 2011; Sweeney et al. 2018). Administration of TNF-like weak inducer of apoptosis (TWEAK) results in increased BBB permeability in mice due to decreases the level of ZO-1 in BMECs and increases the permeability of ECs monolayer (Wen et al. 2015).
ECs-PCs interactions are crucial for BBB formation and properties. Occludin, claudin-5, and ZO-1 expression can be decreased due to PCs deficiency (Bell et al. 2010). TJs and efflux transporters limit paracellular transport and control the entry of most therapeutic agents. Mouse-derived immortalized endothelial cell lines that present higher expression of claudin-5, occludins, and ZO-1 develop a tighter barrier. Loss of PCs can lead to the microvascular degeneration and BBB disruption. Additively, the actin cytoskeleton is supportive of the junctional proteins to anchor in the ECs (Fig. 4) (Knox et al. 2022).
BBB Permeability
Gases, e.g. carbon dioxide and oxygen, and small lipophilic molecules (< 400 Da) freely diffuse through the BBB, while the transport of other molecules is strictly regulated (Zhao et al. 2015). Substrate-specific transporters allow the distribution of amino acids, carbohydrates, fatty acids, nucleotides, hormones, amines, inorganic ions, or vitamins (Fig. 5) (Sweeney et al. 2019). Ions require transporters, such as ATPases (Zlokovic 2011). The brain has no system for energy storage; energy substrates are delivered to the brain and used directly after crossing the barrier (Sweeney et al. 2019). GLUT-1, monocarboxylate transporter 1 (MCT-1) for lactate transport, and transporters for large neutral and cationic essential amino acids are expressed on the both sides of BBB (Fig. 5) (Zlokovic 2011). GLUT-1, uniporter for glucose transport, is highly expressed in ECs (Winkler et al. 2015). The density of this transporter is significantly greater on the abluminal side of ECs that favor glucose transport from the blood into the brain (Simpson et al. 2001). It has a single binding site for glucose or other hexoses. While glucose concentration is lower in the brain in comparison to peripheral blood, GLUT-1 transports circulating glucose through the BBB. BMECs nutrient transporters facilitate the transport according to the concentration gradients (Zlokovic 2011; Deng et al. 2014). Haploid deficiency in GLUT-1 in murine ECs leads to TJ and basement membrane protein loss (Winkler et al. 2015). ATP-binding cassette (ABC) transporters, e.g. ABCB1 protein, are responsible for the active efflux of xenobiotics, drugs, and drug conjugates to prevent its accumulation in the brain. ABCB1 efflux Alzheimer’s Aβ toxin from the brain to the blood (Fig. 5) (Wang et al. 2016). Transporters for peptides, such as ABC proteins, include the endothelial receptor for natural anticoagulant, activated protein C (APC) (Fig. 5) (Guzman-Cottrill et al. 2008; Zlokovic 2011). Physiological activity of the BBB protects the CNS against any harmful substances as well as provides nutrients to the brain. However, on-demand BBB opening may help increase therapeutic agent penetration and improve treatment efficiency (Chen et al. 2022). Focused ultrasound (FUS) was used to increase BBB permeability temporarily. Except for affecting the tight packing of EC, astrocytes and miocytes are also activated by FUS (Chen et al. 2021). RBE4 were exposed to 12 MHz FUS for up to 30 min, which expanded intercellular spaces by remodeling the distribution of ZO-1. Nevertheless, FUS did not alter cell proliferation and oxidative marker, confirming the safety (Branca et al. 2023).
BBB Dysfunction, Aging, and Neurodegeneration
The brain consumes ~ 20% and ~ 25% of body’s oxygen and glucose, respectively. When cerebral blood flow stops, neurons become to be damaged within minutes. Neurovascular disintegration, BBB and microvascular dysfunction and degeneration in the brain lead to neurodegenerative diseases. Deficiency in MVNs yields reduced brain nourishment and impaired clearance of neurotoxins. Vascular dysfunction is directly associated with neurodegeneration and neural impairment. Endothelial metabolic dysfunction, hypoperfusion, hypoxia, and BBB breakdown are the key pathways of vascular dysfunction and neurodegenerative disorders (Knox et al. 2022). In case of healthy aging, BBB integrity is impaired in the hippocampus, but with no cognitive disruption (Montagne et al. 2015). Increased IgG leakage into the brain, reduction of occludin, detachment of pericytes and decreased expression of endothelial genes induced by pericytes as well as decreased glycoprotein P (P-gp) expression and glucose uptake (due to change in expression of GLUT-1) constitute a hallmark of healthy aging (Erickson and Banks 2019; Yang et al. 2020; Knox et al. 2022).
BBB breakdown in disease is attributable to PCs detachment. Leakage of serum proteins and focal microhemorrhages lead to hemoglobin release, a source of iron, that catalyzes the formation of ROS. As a result, neurons are injured. The other representations of BBB breakdown are: altered paracellular and cellular transport, demyelination and neuronal damage, decreased TJ protein expression, detached and swollen astrocytes, pericytes loss and dysfunction, leukocyte infiltration, basement membrane thinning and activated microglia (Knox et al. 2022). Hypoperfusion, a reduced cerebral blood flow, and hypoxia promoted by vasogenic edema exacerbate neuronal damage. The result of these processes is diminished ATPases activity and ATP synthesis, altered pH and electrolyte balance, and consequently accumulation of neurotoxins and glutamate in the brain (Kalaria 2010; Moskowitz et al. 2010). Hypoperfusion affects protein synthesis and therefore synaptic plasticity (Iadecola 2004). Neurotoxic proteins (e.g. plasmin, fibrin, and thrombin) can enter the brain, when BBB is untight (Zlokovic 2011). Neuronal laminin is degraded by accumulated plasmin that promotes neuronal injury (Chen and Strickland 1997). The level of TJ and AJ proteins decreased in neurodegenerative disorders like AD or multiple sclerosis (Bell et al. 2010; Zlokovic 2011). These neurological conditions cause leukocytes leakage into the brain and loss of zonula occludens and occludin (Ballabh et al. 2004).
BBB Under Hypoxia
Hypoxia in the brain leads to its damage and BBB breakdown. It could be attributed to strokes or neurologic diseases. Low-oxygen concentration influences the expression levels of TJs (Brown and Davis 2005; Nzou et al. 2020) in BBB, efflux transporters, solute carriers, and receptors for nutrients and hormones. Hypoxia-induced cell response is HIF-1α mediated (Lee et al. 2012; Engelhardt et al. 2014) and it is cell-specific. ECs are more sensitive to hypoxia than ACs and PCs (Engelhardt et al. 2015). Moreover, ACs and PCs represent a synergistic effect in barrier improvement, when co-cultured with RBE4 under O2 deprivation (Hayashi et al. 2004; Al Ahmad et al. 2009). Engelhardt et al. reported that GLUT-1 (Yamagata et al. 2004) and VEGF expression in the ECs under O2 deprivation was increased, when compared to the ACs and PCs (Engelhardt et al. 2015). Also, in vivo study on mice showed increased levels of VEGF mRNA and protein. VEGF is an angiogenic growth factor, thus inducing new vessel formation leading to enhanced vascular permeability (Schoch et al. 2002). Yeh et al. demonstrated VEGF expression regulation by the HIF-1α. They used a rat animal model to inhibit HIF-1α by 3-(5’-hydroxymethyl-2’-furyl)-1-benzylindazole, leading to decreased VEGF production and cause the BBB protection (Yeh et al. 2007). Hypoxia-induced changes in the stem cell-derived human BMECs and immortalized BBB cell line were verified by Page et al. The TJs complexes in both cell lines were disrupted (Fischer et al. 2002; Al Ahmad et al. 2009). However, AJs remain unaffected (Fig. 6) (Page et al. 2016). Claudin-5 expression was analyzed in the monolayer culture of bEND.3. Within the barrier formation by bEND.3 cells, claudin-5 was relocated from the cytoplasm to the plasma membrane, creating TJ. While cells were exposed to hypoxia, claudin-5 expression was decreased (Koto et al. 2007). RBE4 exposed to hypoxia showed increased ROS formation providing EC disintegration. This phenomenon led Ahmad et al. to inhibit ROS generation by diphenyliodiunium and verify, whether it leads to maintaining BBB function, demonstrating promising results of using ROS inhibitors for supporting BBB function during stroke or cerebrovascular injury (Al Ahmad et al. 2012).
However, in this review, the disruptive effect of hypoxia on BBB is widely discussed. Ozgür et al. reported that functional BBB with tight monolayer of bovine brain capillary endothelial cells (BCECs) was present during the early development of the brain vasculature, when the oxygen concentration was low. The expression level of the transport proteins, such as GLUT-1 and P-gp was increased under hypoxia (Park et al. 2018), which was confirmed by the increased glucose uptake. Furthermore, BBB tightening was observed when confluent cells were exposed to hypoxia (Ozgür et al. 2022).
BBB Under Neurotoxic Condition
Many chemicals, such as heavy metals or pesticides are neurotoxic. The toxic effect on the brain depends on the dose, brain development, and mode of action (Pistollato et al. 2020). Moreover, when pregnant women, newborns, or young people are exposed to neurotoxins, the normal development and maturation of the nervous system can be disturbed (Parran et al. 2005). Metals are essential for proper CNS functioning, however when their optimal level is exceeded, or heavy metals cross the BBB barrier, leakage occurs, especially when the barrier is immature (Lewis and Zheng 2007). Similar to hypoxia, the response to the metals is cell-depended. Usually, ACs became the target of metal toxicity (Li et al. 2021). However, lead (Pb) rather accumulates in ECs than in another BBB cells (Zheng et al. 2003). In vivo study on rats showed that neurotoxins, such as Pb, increase BBB permeability due downregulation of TJ proteins, ZO-1, and occludin. Interestingly, when a low and high dose of Pb was compared, a significant difference in protein expression was noticed (Struzyńska et al. 1997). Low Pb dosage decreased the expression of occludin, while the level of ZO-1 was unaffected. This indicates that ZO-1 is less sensitive to Pb exposure (Song et al. 2014). Mercury (Hg) provoke BBB leakage, however the level of toxicity, thus barrier breakdown depends on Hg compound. Inorganic Hg is less toxic than organic ones, for example, methylmercury (MeHg). Highly lipophilic MeHg can easily diffuse through the cell membrane without any carrier proteins (Zheng et al. 2003). Rats had been exposed to the MeHg, which induced BBB damage due to the upregulation of VEGF expression. This phenomenon was predominant in astrocytes (Takahashi et al. 2017). Hirooka et al. observed similar dependence within the human brain microvascular endothelial cells and PCs, where the MeHg increased VEGF expression and therefore provided barrier leakage (Hirooka et al. 2013). Except for the disruptive effect of metals, it was shown that zinc (Zn) may have beneficial effect by blocing the action of cadmium, thus preventing ZO-1 downregulation and dislocation (Branca et al. 2022). Interestingly, barrier disarrangement by heavy metals could be treated with chelation therapies (Ferrero 2022).
Parran et al. analyzed the effect of pesticide—chlorpyrifos on BBB formed by co-culture of BMEC with rat astrocytes, showing increased barrier permeability (Parran et al. 2005). Moreover, the integrity of BBB built from the same cells as described above was verified with another pesticide—malathion; again, showing decreased tightness (Balbuena et al. 2010). The monolayer of iPSC-derived BMECs was treated with glyphosate (GPH)—a herbicide, to assess the BBB permeability and TJs proteins. The glucose uptake increased, as the GLUT-1 expression was greater than in the untreated cells. Furthermore, both claudin-5 (Fig. 7A) and occludin (Fig. 7B) expression were downregulated, confirming BBB breakdown. Here, the toxic effect of metals and pesticides on BBB was described, as those two groups of compounds are the most frequent and least examined recently (Martinez and Al-Ahmad 2019).
Conclusions and Perspectives
Restoring the disrupted BBB may decelerate the progression of the neurodegenerative diseases. Tightening the barrier could restrict the negative effect of the inflammation. In vitro BBB models are useful tools to study BBB physiology and molecular mechanisms that occur in the barrier. In vivo models are used for drug screenings and safety and efficacy assessment, while clinical models are useful for studying BBB function and disruption in diseases (Knox et al. 2022).
BBB models are essential for neurodegenerative disease studies and drug discoveries. At the beginning 2D models were used, then that 3D systems were developed to better mimic neural conditions (Mantecón-Oria et al. 2022). Functional tests performed on 2D models were not enough credible to use them as a reference model for BBB studies (Buzhdygan et al. 2020; Hajal et al. 2022). The simplest 3D model, transwell, is cost-effective and fast, nevertheless, the lack of shear-stress and comparatively low levels of BBB regulatory proteins constitute the main disadvantages of this model (Waldau 2019; Wu et al. 2021). Moving forward to Matrigel based models, in which ECs form tube-like structures, we are becoming closer to the system for physiological mechanisms studies. This approach is useful for gene expression profile assessment, infectious experiments. Nevertheless, may be immunogenic and vascular permeabilities are still far away from in vivo conditions (Berg et al. 2018; Hajal et al. 2022; Simöes Da Gama and Morin-Brureau 2022). Therefore spheroidal model, auto-assembled without scaffolding material, has been developed. Spheroids allow to study of cellular interactions, gene expression, vessel morphology, and functional barrier properties. The limitation is the fact that spheroid can be tested only once as it disintegrate very easily (Waldau 2019; Wu et al. 2021; Hajal et al. 2022). The last one model discussed in this review, tissue-on-a-chip, uses microfluidic channels and is appropriate for drug delivery and CNS neurotoxicity studies. The ability to generate shear stress through stimulated blood flow in BBB models makes this technique very promising (Kaisar et al. 2017; Campisi et al. 2018; Wu et al. 2021).
Many treatments fail at the screening stage due to inability to cross the BBB; platforms that better mimic the functionality of the human barrier are needed. Current models that facilitate cellular interactions are still far from in vivo BBB, therefore the development of better 3D models, the microfluidics, and 4D biofabrication will be the future of BBB in vitro modelling (Mantecón-Oria et al. 2022). Combination of patient-derived iPSCs with Organ-Chip technology can serve to provide a platform for modelling disorders, drug discovery, and personalized medicine (Vatine et al. 2019).
Data Availability
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Abbreviations
- ABC:
-
ATP-binding cassette
- ACs:
-
Astrocytes
- AD:
-
Alzheimer’s disease
- AJ:
-
Adherent junction
- APC:
-
Activated protein C
- BBB:
-
Blood brain barrier
- BCECs:
-
Bovine brain capillary endothelial cells
- bEND.3:
-
Mouse brain endothelial cells
- BMECs:
-
Brain microvascular endothelial cells
- CNS:
-
Central nervous system
- CPS:
-
Chlorpyrifos
- ECM:
-
Extracellular matrix
- ECs:
-
Endothelial cells
- ESAM:
-
Endothelial cell-selective adhesion molecule
- FUS:
-
Focused ultrasound
- GLUT-1:
-
Glucose transporter 1
- hCOs:
-
Human cortical organoids
- hESCs:
-
Human embryonic stem cells
- iPSCs:
-
Induced pluripotent stem cells
- JAM:
-
Junctional adhesion molecules
- MAGUK:
-
Membrane-associated guanylate kinase
- MCT-1:
-
Monocarboxylate transporter 1
- MVNs:
-
Microvascular networks
- NVU:
-
Neurovascular units
- PCs:
-
Pericytes
- PECAM-1:
-
Platelet endothelial cell adhesion molecule-1
- P-gp:
-
Glycoprotein P
- RBE4:
-
Rat brain endothelial cells
- ROS:
-
Reactive oxygen species
- TJ:
-
Tight junctions
- TWEAK:
-
TNF-like weak inducer of apoptosis
- VEGF:
-
Vascular endothelial growth factor
- ZOs:
-
Zonula occludens
References
Aazmi A et al (2022) Vascularizing the brain in vitro. Science. https://doi.org/10.1016/j.isci.2022.104110
Al Ahmad A, Gassmann M, Ogunshola OO (2009) Maintaining blood–brain barrier integrity: pericytes perform better than astrocytes during prolonged oxygen deprivation. J Cell Physiol. https://doi.org/10.1002/jcp.21638
Al Ahmad A, Gassmann M, Ogunshola OO (2012) Involvement of oxidative stress in hypoxia-induced blood–brain barrier breakdown. Microvasc Res. https://doi.org/10.1016/j.mvr.2012.05.008
Armulik A et al (2010) Pericytes regulate the blood–brain barrier. Nature. https://doi.org/10.1038/nature09522
Bagchi S et al (2019) In-vitro blood–brain barrier models for drug screening and permeation studies: an overview. Drug Des Dev Ther. https://doi.org/10.2147/DDDT.S218708
Balbuena P et al (2010) Comparison of two blood–brain barrier in vitro systems: cytotoxicity and transfer assessments of malathion/oxon and lead acetate. Toxicol Sci. https://doi.org/10.1093/toxsci/kfq001
Ballabh P, Braun A, Nedergaard M (2004) The blood–brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2003.12.016
Bell RD et al (2010) Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging. Neuron. https://doi.org/10.1016/j.neuron.2010.09.043
Berg J et al (2018) Optimization of cell-laden bioinks for 3D bioprinting and efficient infection with influenza A virus. Sci Rep. https://doi.org/10.1038/s41598-018-31880-x
Bergmann S et al (2018) Blood–brain-barrier organoids for investigating the permeability of CNS therapeutics. Nat Protoc. https://doi.org/10.1038/s41596-018-0066-x
Bernardo-Castro S et al (2020) Pathophysiology of blood–brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol 11(December):1–24. https://doi.org/10.3389/fneur.2020.594672
Bhalerao A et al (2020) In vitro modeling of the neurovascular unit: advances in the field. Fluids Barriers CNS. https://doi.org/10.1186/s12987-020-00183-7
Branca JJV et al (2022) The protection of zinc against acute cadmium exposure: a morphological and molecular study on a BBB in vitro model. Cells. https://doi.org/10.3390/cells11101646
Branca JJV et al (2023) Morphological and functional effects of ultrasound on blood–brain barrier transitory opening: an in vitro study on rat brain endothelial cells. Cells 12(1):1–14. https://doi.org/10.3390/cells12010192
Brown RC, Davis TP (2005) Hypoxia/aglycemia alters expression of occludin and actin in brain endothelial cells. Biochem Biophys Res Commun. https://doi.org/10.1016/j.bbrc.2004.12.123
Burgess A, Hynynen K (2016) Microbubble-assisted ultrasound for drug delivery in the brain and central nervous system. Adv Exp Med Biol. https://doi.org/10.1007/978-3-319-22536-4_16
Buzhdygan TP et al (2020) The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2020.105131
Cakir B et al (2019) Engineering of human brain organoids with a functional vascular-like system. Nat Methods. https://doi.org/10.1038/s41592-019-0586-5
Campisi M et al (2018) 3D self-organized microvascular model of the human blood–brain barrier with endothelial cells, pericytes and astrocytes. Biomaterials. https://doi.org/10.1016/j.biomaterials.2018.07.014
Cardoso FL, Brites D, Brito MA (2010) Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. https://doi.org/10.1016/j.brainresrev.2010.05.003
Chen ZL, Strickland S (1997) Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell. https://doi.org/10.1016/S0092-8674(00)80483-3
Chen KT et al (2021) Neuronavigation-guided focused ultrasound for transcranial blood–brain barrier opening and immunostimulation in brain tumors. Sci Adv. https://doi.org/10.1126/sciadv.abd0772
Chen S et al (2022) A review of bioeffects induced by focused ultrasound combined with microbubbles on the neurovascular unit. J Cereb Blood Flow Metab 42(1):3–26. https://doi.org/10.1177/0271678X211046129
Cho C et al (2017) Blood–brain-barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nat Commun 8:1–14. https://doi.org/10.1038/ncomms15623
Christophe B et al (2020) Statin therapy in ischemic stroke models: a meta-analysis. Transl Stroke Res. https://doi.org/10.1007/s12975-019-00750-7
Chung TD et al (2022) Effects of acute and chronic oxidative stress on the blood–brain barrier in 2D and 3D in vitro models. Fluids Barriers CNS. https://doi.org/10.1186/s12987-022-00327-x
Deng D et al (2014) Crystal structure of the human glucose transporter GLUT1. Nature. https://doi.org/10.1038/nature13306
Dong X (2018) Current strategies for brain drug delivery. Theranostics. https://doi.org/10.7150/thno.21254
Dunton AD et al (2021) Form and function of the vertebrate and invertebrate blood–brain barriers. Int J Mol Sci. https://doi.org/10.3390/ijms222212111
Eilenberger C et al (2021) A microfluidic multisize spheroid array for multiparametric screening of anticancer drugs and blood–brain barrier transport properties. Adv Sci. https://doi.org/10.1002/advs.202004856
Engelhardt S et al (2014) Hypoxia selectively disrupts brain microvascular endothelial tight junction complexes through a hypoxia-inducible factor-1 (HIF-1) dependent mechanism. J Cell Physiol. https://doi.org/10.1002/jcp.24544
Engelhardt S et al (2015) Differential responses of blood-brain barrier associated cells to hypoxia and ischemia: a comparative study. Fluids Barriers CNS. https://doi.org/10.1186/2045-8118-12-4
Erickson MA, Banks WA (2019) Age-associated changes in the immune system and blood–brain barrier functions. Int J Mol Sci. https://doi.org/10.3390/ijms20071632
Ferrero ME (2022) Neuron protection by EDTA may explain the successful outcomes of toxic metal chelation therapy in neurodegenerative diseases. Biomedicines. https://doi.org/10.3390/biomedicines10102476
Fischer S et al (2002) Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. https://doi.org/10.1006/mvre.2001.2367
Fu BM, Zhao Z, Zhu D (2021) Blood–brain barrier (BBB) permeability and transport measurement in vitro and in vivo. Methods Mol Biol. https://doi.org/10.1007/7651_2020_308
Garrido-Urbani S, Bradfield PF, Imhof BA (2014) Tight junction dynamics: the role of junctional adhesion molecules (JAMs). Cell Tissue Res. https://doi.org/10.1007/s00441-014-1820-1
Guzman-Cottrill J, Nadel S, Goldstein B (2008) The Systemic Inflammatory Response Syndrome (SIRS), sepsis, and septic shock. Princ Pract Pediatr Infect Dis. https://doi.org/10.1016/B978-0-7020-3468-8.50018-3
Hajal C et al (2022) Engineered human blood–brain barrier microfluidic model for vascular permeability analyses. Nat Protoc. https://doi.org/10.1038/s41596-021-00635-w
Hatherell K et al (2011) Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods. https://doi.org/10.1016/j.jneumeth.2011.05.012
Hayashi K et al (2004) Effects of hypoxia on endothelial/pericytic co-culture model of the blood–brain barrier. Regul Pept. https://doi.org/10.1016/j.regpep.2004.05.023
Hirooka T et al (2013) Expression of VEGF-related proteins in cultured human brain microvascular endothelial cells and pericytes after exposure to methylmercury. J Toxicol Sci. https://doi.org/10.2131/jts.38.837
Hladky SB, Barrand MA (2016) Fluid and ion transfer across the blood-brain and blood-cerebrospinal fluid barriers; a comparative account of mechanisms and roles. Fluids Barriers CNS. https://doi.org/10.1186/s12987-016-0040-3
Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimer’s disease. Nat Rev Neurosci. https://doi.org/10.1038/nrn1387
Jiang X et al (2018) Blood–brain barrier dysfunction and recovery after ischemic stroke. Prog Neurobiol. https://doi.org/10.1016/j.pneurobio.2017.10.001
Kadry H et al (2021) Comparative assessment of in vitro BBB tight junction integrity following exposure to cigarette smoke and e-cigarette vapor: a quantitative evaluation of the protective effects of metformin using small-molecular-weight paracellular markers. Fluids Barriers CNS. https://doi.org/10.1186/s12987-021-00261-4
Kaisar MA et al (2017) New experimental models of the blood–brain barrier for CNS drug discovery. Expert Opin Drug Discov. https://doi.org/10.1080/17460441.2017.1253676
Kalaria RN (2010) Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. https://doi.org/10.1111/j.1753-4887.2010.00352.x
Kilic O et al (2016) Brain-on-a-chip model enables analysis of human neuronal differentiation and chemotaxis. Lab Chip. https://doi.org/10.1039/c6lc00946h
Kleinman HK, Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer.2005.05.004
Knox EG et al (2022) The blood–brain barrier in aging and neurodegeneration. Mol Psychiatry 27(6):2659–2673. https://doi.org/10.1038/s41380-022-01511-z
Komura T et al (2015) Optimization of surface-immobilized extracellular matrices for the proliferation of neural progenitor cells derived from induced pluripotent stem cells. Biotechnol Bioeng. https://doi.org/10.1002/bit.25636
Koto T et al (2007) Hypoxia disrupts the barrier function of neural blood vessels through changes in the expression of claudin-5 in endothelial cells. Am J Pathol. https://doi.org/10.2353/ajpath.2007.060693
Kozlowski MT, Crook CJ, Ku HT (2021) Towards organoid culture without Matrigel. Commun Biol. https://doi.org/10.1038/s42003-021-02910-8
Kuchibhotla KV et al (2009) Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science (new York). https://doi.org/10.1126/science.1169096
Lee SW et al (2012) Hypoxic priming of mESCs accelerates vascular-lineage differentiation through HIF1-mediated inverse regulation of Oct4 and VEGF. EMBO Mol Med. https://doi.org/10.1002/emmm.201101107
Lewis ZS, Zheng W (2007) Early lead exposure increases the leakage of the blood-cerebrospinal fluid barrier, in vitro. Human Exp Toxicol. https://doi.org/10.1177/0960327107070560
Li B et al (2021) Astrocytes in heavy metal neurotoxicity and neurodegeneration. Brain Res 1752(77):1–24. https://doi.org/10.1016/j.brainres.2020.147234
Lippmann ES et al (2013) Modeling the blood–brain barrier using stem cell sources. Fluids Barriers CNS 10(1):1–14. https://doi.org/10.1186/2045-8118-10-2
Logan S et al (2019) Studying human neurological disorders using induced pluripotent stem cells: from 2D monolayer to 3D organoid and blood brain barrier models. Compr Physiol. https://doi.org/10.1002/cphy.c180025
Mansour AA et al (2018) An in vivo model of functional and vascularized human brain organoids. Nat Biotechnol. https://doi.org/10.1038/nbt.4127
Mantecón-Oria M et al (2022) On the quest of reliable 3D dynamic in vitro blood–brain barrier models using polymer hollow fiber membranes: pitfalls, progress, and future perspectives. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2022.1056162
Martinez A, Al-Ahmad AJ (2019) Effects of glyphosate and aminomethylphosphonic acid on an isogeneic model of the human blood–brain barrier. Toxicol Lett. https://doi.org/10.1016/j.toxlet.2018.12.013
Montagne A et al (2015) Blood–brain barrier breakdown in the aging human hippocampus. Neuron. https://doi.org/10.1016/j.neuron.2014.12.032
Moskowitz MA, Lo EH, Iadecola C (2010) The science of stroke: mechanisms in search of treatments. Neuron. https://doi.org/10.1016/j.neuron.2010.07.002
Nakagawa S et al (2009) A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int. https://doi.org/10.1016/j.neuint.2008.12.002
Nitta T et al (2003) Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J Cell Biol. https://doi.org/10.1083/jcb.200302070
Nzou G, et al. (2020) Author correction: multicellular 3D neurovascular unit model for assessing hypoxia and neuroinflammation induced blood–brain barrier dysfunction (Scientific Reports, (2020), 10, 1, (9766), https://doi.org/10.1038/s41598-020-66487-8), Sci Rep. https://doi.org/10.1038/s41598-020-77348-9.
Ozgür B et al (2022) Hypoxia increases expression of selected blood–brain barrier transporters GLUT-1, P-gp, SLC7A5 and TFRC, while maintaining barrier integrity, in brain capillary endothelial monolayers. Fluids Barriers CNS. https://doi.org/10.1186/s12987-021-00297-6
Page S, Munsell A, Al-Ahmad AJ (2016) Cerebral hypoxia/ischemia selectively disrupts tight junctions complexes in stem cell-derived human brain microvascular endothelial cells. Fluids Barriers CNS. https://doi.org/10.1186/s12987-016-0042-1
Pandit R, Chen L, Götz J (2020) The blood–brain barrier: physiology and strategies for drug delivery. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2019.11.009
Pardridge WM (2015) Targeted delivery of protein and gene medicines through the blood–brain barrier. Clin Pharmacol Ther. https://doi.org/10.1002/CPT.18
Pardridge WM (2022) A historical review of brain drug delivery. Pharmaceutics. https://doi.org/10.3390/pharmaceutics14061283
Park T-E et al (2018) Hypoxia-enhanced blood–brain barrier chip recapitulates human barrier function, drug penetration, and antibody shuttling properties. bioRxiv. https://doi.org/10.1101/482463
Parran DK et al (2005) Chlorpyrifos alters functional integrity and structure of an in vitro BBB model: co-cultures of bovine endothelial cells and neonatal rat astrocytes. NeuroToxicol. https://doi.org/10.1016/j.neuro.2004.07.003
Patel R, Alahmad AJ (2016) Growth-factor reduced Matrigel source influences stem cell derived brain microvascular endothelial cell barrier properties. Fluids Barriers CNS. https://doi.org/10.1186/s12987-016-0030-5
Peppiatt CM et al (2006) Bidirectional control of CNS capillary diameter by pericytes. Nature. https://doi.org/10.1038/nature05193
Pistollato F et al (2020) Assessment of developmental neurotoxicity induced by chemical mixtures using an adverse outcome pathway concept. Environ Health A Global Access Sci Sour. https://doi.org/10.1186/s12940-020-00578-x
Prasad M et al (2021) Organoid technology: a reliable developmental biology tool for organ-specific nanotoxicity evaluation. Front Cell Develop Biol. https://doi.org/10.3389/fcell.2021.696668
Rice O, Surian A, Chen Y (2022) Modeling the blood–brain barrier for treatment of central nervous system (CNS) diseases. J Tissue Eng. https://doi.org/10.1177/20417314221095997
Schoch HJ, Fischer S, Marti HH (2002) Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain. https://doi.org/10.1093/brain/awf257
Sengillo JD et al (2013) Deficiency in mural vascular cells coincides with blood–brain barrier disruption in alzheimer’s disease. Brain Pathol. https://doi.org/10.1111/bpa.12004
Simöes Da Gama C, Morin-Brureau M (2022) Study of BBB dysregulation in neuropathogenicity using integrative human model of blood–brain barrier. Front Cell Neurosci. https://doi.org/10.3389/fncel.2022.863836
Simonneau C et al (2021) Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays. Fluids Barriers CNS. https://doi.org/10.1186/s12987-021-00276-x
Simpson IA et al (2001) Glucose transporter asymmetries in the bovine blood–brain barrier. J Biol Chem. https://doi.org/10.1074/jbc.M010897200
Sivandzade F, Cucullo L (2018) In-vitro blood–brain barrier modeling: a review of modern and fast-advancing technologies. J Cereb Blood Flow Metab. https://doi.org/10.1177/0271678X18788769
Song H et al (2014) Reduction of brain barrier tight junctional proteins by lead exposure: role of activation of nonreceptor tyrosine kinase Src via chaperon GRP78. Toxicol Sci. https://doi.org/10.1093/toxsci/kfu007
Stenman JM et al (2008) Canonical Wnt signaling regulates organ-specific assembly and differentiation of CNS vasculature. Science. https://doi.org/10.1126/science.1164594
Stone NL, England TJ, O’Sullivan SE (2019) A novel transwell blood brain barrier model using primary human cells. Front Cell Neurosci 13(June):1–11. https://doi.org/10.3389/fncel.2019.00230
Struzyńska L et al (1997) Lead-induced abnormalities in blood-brain barrier permeability in experimental chronic toxicity. Mol Chem Neuropathol. https://doi.org/10.1007/BF02815125
Sun J et al (2022) Comparative studies between the murine immortalized brain endothelial cell line (bEnd3) and induced pluripotent stem cell-derived human brain endothelial cells for paracellular transport. PLoS ONE 17(5 May):1–17. https://doi.org/10.1371/journal.pone.0268860
Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol. https://doi.org/10.1038/nrneurol.2017.188
Sweeney MD et al (2019) Blood–brain barrier: from physiology to disease and back. Physiol Rev. https://doi.org/10.1152/physrev.00050.2017
Taheri S et al (2011) Blood–brain barrier permeability abnormalities in vascular cognitive impairment. Stroke. https://doi.org/10.1161/STROKEAHA.110.611731
Takahashi T et al (2017) Methylmercury causes blood–brain barrier damage in rats via upregulation of vascular endothelial growth factor expression. PLoS ONE. https://doi.org/10.1371/journal.pone.0170623
Takano T et al (2007) Two-photon imaging of astrocytic Ca2+ signaling and the microvasculature in experimental mice models of Alzheimer’s disease. Ann N Y Acad Sci. https://doi.org/10.1196/annals.1379.004
Thrippleton MJ et al (2019) Quantifying blood–brain barrier leakage in small vessel disease: review and consensus recommendations. Alzheimer’s Dementia. https://doi.org/10.1016/j.jalz.2019.01.013
Tietz S, Engelhardt B (2015) Brain barriers: crosstalk between complex tight junctions and adherens junctions. J Cell Biol. https://doi.org/10.1083/jcb.201412147
Tornavaca O et al (2015) ZO-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis, and barrier formation. J Cell Biol. https://doi.org/10.1083/jcb.201404140
Urich E et al (2013) Multicellular self-assembled spheroidal model of the blood brain barrier. Sci Rep. https://doi.org/10.1038/srep01500
Vatine GD et al (2019) Human iPSC-derived blood–brain barrier chips enable disease modeling and personalized medicine applications. Cell Stem Cell. https://doi.org/10.1016/j.stem.2019.05.011
Vorbrodt AW, Dobrogowska DH (2003) Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist’s view. Brain Res Rev. https://doi.org/10.1016/S0165-0173(03)00177-2
Waldau B (2019) Using miniature brain implants in rodents for novel drug discovery. Expert Opin Drug Discov. https://doi.org/10.1080/17460441.2019.1577816
Wang W, Bodles-Brakhop AM, Barger SW (2016) A role for P-glycoprotein in clearance of alzheimer amyloid-peptide from the brain. Curr Alzheimer Res. https://doi.org/10.2174/1567205013666160314151012
Wang Y et al (2018) Human brain organoid-on-a-chip to model prenatal nicotine exposure. Lab Chip. https://doi.org/10.1039/c7lc01084b
Wang H et al (2021) Reconstituting neurovascular unit with primary neural stem cells and brain microvascular endothelial cells in three-dimensional matrix. Brain Pathol. https://doi.org/10.1111/bpa.12940
Wang Z et al (2022) CNS organoid surpasses cell-laden microgel assembly to promote spinal cord injury repair. Research. https://doi.org/10.34133/2022/9832128
Watanabe T et al (2013) Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bend.3, bend.5 and mouse brain endothelial cell 4. Biol Pharm Bull 36(3):492–495. https://doi.org/10.1248/bpb.b12-00915
Wei X et al (2023) iPSCs-derived mesenchymal stromal cells mitigate anxiety and neuroinflammation in aging female mice. Int J Biochem Cell Biol 155:106347. https://doi.org/10.1016/J.BIOCEL.2022.106347
Weksler B, Romero IA, Couraud PO (2013) The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):1–10. https://doi.org/10.1186/2045-8118-10-16
Wen J et al (2015) TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice. J Autoimmun. https://doi.org/10.1016/j.jaut.2015.03.005
Winkler EA et al (2015) GLUT1 reductions exacerbate Alzheimer’s disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci. https://doi.org/10.1038/nn.3966
Wu YC et al (2021) Blood–brain barrier and neurodegenerative diseases—modeling with ipsc-derived brain cells. Int J Mol Sci. https://doi.org/10.3390/ijms22147710
Yamagata K et al (2004) Hypoxia-induced changes in tight junction permeability of brain capillary endothelial cells are associated with IL-1beta and nitric oxide. Neurobiol Dis. https://doi.org/10.1016/j.nbd.2004.08.001
Yang AC et al (2020) Physiological blood–brain transport is impaired with age by a shift in transcytosis. Nature. https://doi.org/10.1038/s41586-020-2453-z
Yeh WL et al (2007) Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1α accumulation and VEGF expression. Mol Pharmacol. https://doi.org/10.1124/mol.107.036418
Yemisci M et al (2015) Systemically administered brain-targeted nanoparticles transport peptides across the blood-brain barrier and provide neuroprotection. J Cerebral Blood Flow Metab. https://doi.org/10.1038/jcbfm.2014.220
Zhao Z et al (2015) Establishment and dysfunction of the blood–brain barrier. Cell. https://doi.org/10.1016/j.cell.2015.10.067
Zheng W, Aschner M, Ghersi-Egea JF (2003) Brain barrier systems: a new frontier in metal neurotoxicological research. Toxicol Appl Pharmacol. https://doi.org/10.1016/S0041-008X(03)00251-5
Zidarič T, Gradišnik L, Velnar T (2022) Astrocytes and human artificial blood–brain barrier models. Bosn J Basic Med Sci 22(5):651–672. https://doi.org/10.17305/bjbms.2021.6943
Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nat Rev Neurosci. https://doi.org/10.1038/nrn3114
Funding
This research was funded in whole or in part by NCN grant no. 2021/41/B/ST4/02000. For the purpose of Open Access, the author has applied a CC-BY public copyright licence to any Author Accepted Manuscript (AAM) version arising from this submission.
Author information
Authors and Affiliations
Contributions
J.K.-K. and Z.K. wrote the main manuscript test. J.K.-K. prepare figures 1-3, 6 and 7; Z.K. prepare figures 4 and 5. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Korszun-Karbowniczak, J., Krysiak, Z.J., Saluk, J. et al. The Progress in Molecular Transport and Therapeutic Development in Human Blood–Brain Barrier Models in Neurological Disorders. Cell Mol Neurobiol 44, 34 (2024). https://doi.org/10.1007/s10571-024-01473-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10571-024-01473-6